在炎症性肠病中临床决策模仿:从炎症性肠病实践管理 LIVE
Hannah W Fiske1, Christopher Ward2, Samir A Shah3
1Department of Internal Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Crohn's & colitis 360
|May 9, 2024
概括
在IBD LIVE中讨论的很大一部分病例不是炎症性肠病 (IBD),而是模仿性肠病,这凸显了需要仔细差异诊断的需要. 错误诊断可能导致不适当的治疗和不良事件,影响患者护理质量和成本.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- IBD LIVE是一个每周的视频会议,讨论具有挑战性的炎症性肠病 (IBD) 病例.
- 显著的数量呈现的病例被确定为IBD模仿,不确认IBD.
- 这项研究对IBD模仿物进行了分类,并分析了它们对临床管理的影响.
研究的目的:
- 在IBD LIVE中呈现的病例进行分类,区分确诊的IBD和IBD模仿者.
- 为了分析IBD的诊断和治疗工作,模仿IBD.
- 了解错误诊断IBD的临床管理影响.
主要方法:
- 审查了从2018年5月到2023年2月在IBD LIVE上存档的371起案件.
- 将病例分类为确诊的IBD和IBD模仿者.
- 对IBD模仿的诊断评估和治疗方法的分析.
主要成果:
- 82.5%的病例被确认为IBD (克罗恩病,性结肠炎,IBD-未分类).
- 17.5%的病例 (65/371) 是IBD模仿者,最常见的是药物诱导或血管炎.
- 诊断评估包括活检,手术病理学,基因检测和成像;38%的模仿患者接受了生物药物,其中5人经历了不良事件.
结论:
- IBD和IBD模仿的各种表现需要持续考虑差异诊断.
- 对于被认为IBD患者没有临床反应,对治疗的重新评估至关重要.
- 准确的IBD诊断与模仿对适当,经济有效的患者护理至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Inflammatory Bowel Disease II: Crohn's Disease
219
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
219
Inflammatory Bowel Disease I: Ulcerative Colitis
166
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
166
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158


